Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Vertex Pharmaceuticals Incorporated
About VRTX
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The Company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, acute pain and acromegaly, and it continues to advance clinical and research programs in these areas. It also has a clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including IgA nephropathy, neuropathic pain, APOL1-mediated kidney disease, primary membranous nephropathy, congenital adrenal hyperplasia, ACTH-dependent Cushing's syndrome, autosomal dominant polycystic kidney disease, type 1 diabetes, generalized myasthenia gravis, and myotonic dystrophy type 1. The Company's pipeline also includes PALSONIFY (paltusotine) and atumelnant. PALSONIFY is the once-daily oral therapy for acromegaly.
Market Capitalisation
$131.68B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
352
High today
$525.29
Low today
$514.66
Open price
$0.00
52-week high
$560.25
52-week low
$374.17
Ready to start your investing journey with Stake?
Open an accountHow do I buy VRTX shares in Australia?
Buying VRTX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Vertex Pharmaceuticals Incorporated in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in VRTX
What is the ticker symbol of Vertex Pharmaceuticals Incorporated?
The ticker symbol for Vertex Pharmaceuticals Incorporated is VRTX.
How much is one share of VRTX?
One share of VRTX is valued at $519.24 as of 15 September 2026.
What is the market capitalisation of Vertex Pharmaceuticals Incorporated VRTX?
As of 15 September 2026 Vertex Pharmaceuticals Incorporated has a market cap of $131.68B.
What is the P/E ratio of VRTX?
The Price to Earnings ratio of VRTX is 30.23.
What is the Earnings Per Share of VRTX?
The Earnings Per Share of VRTX is $17.19.
What is the 52-week high for Vertex Pharmaceuticals Incorporated stock?
The Vertex Pharmaceuticals Incorporated 52-week high stock price is $560.25.
What is the 52-week low for Vertex Pharmaceuticals Incorporated stock?
The Vertex Pharmaceuticals Incorporated 52-week low stock price is $374.17.
Can I buy VRTX shares through Stake, an investing platform like Sharesies and Hatch Invest?
Yes, the Stake investing platform allows you to buy VRTX shares and over 9,500 more stocks and ETFs on Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in VRTX on Stake
- Buy VRTX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of VRTX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
VRTX related stocks